Accumulation of advanced glycation end (AGEs) products in intensive care patients: An observational, prospective study

BMC Clinical Pathology

Volumn 10, Issue , 2010, Pages

  Greven, Wendela L ^a   Smit, Jitty M ^a   Rommes, Johannes H ^a   Spronk, Peter E ^a,b  

^a GELRE HOSPITALS   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE IMAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MALE; OBSERVATIONAL STUDY; OXIDATIVE STRESS; SCORING SYSTEM; SEPSIS; SKIN;

EID: 77952497473     PISSN: 14726890     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-10-4     Document Type: Article

References (25)

1. Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independent of severity: a cohort study. J Abiles AP de la Cruz J Castano M Rodriguez-Elvira E Aguayo R Moreno-Torres, et al. Crit Care 2006 10 146 10.1186/cc5068 17040563
2. Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. T Motoyama K Okamoto I Kukita M Hamaguchi Y Kinoshita H Ogawa, Crit Care Med 2003 31 1048 1052 10.1097/01.CCM.0000055371.27268.36 12682471
3. Markers of oxidative stress in ICU clinical settings: present and future. T Grune MM Berger, Curr Opin Clin Nutr Metab Care 2007 10 712 717 10.1097/MCO.0b013e3282f0c97c 18089952
4. Simple noninvasive measurement of skin autofluorescence. R Meerwaldt T Links R Graaff SR Thorpe JW Baynes J Hartog, et al. Ann N Y Acad Sci 2005 1043 290 298 10.1196/annals.1333.036 16037251
5. Glycoxidation and lipoxidation in atherogenesis. JW Baynes SR Thorpe, Free Radic Biol Med 2000 28 1708 1716 10.1016/S0891-5849(00)00228-8 10946212
6. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. T Miyata SC van Ypersele de K Kurokawa JW Baynes, Kidney Int 1999 55 389 399 10.1046/j.1523-1755.1999.00302.x 9987064
7. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. R Meerwaldt JW Hartog R Graaff RJ Huisman TP Links NC den Hollander, et al. J Am Soc Nephrol 2005 16 3687 3693 10.1681/ASN.2005020144 16280473
8. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. R Meerwaldt TP Links R Graaff K Hoogenberg JD Lefrandt JW Baynes, et al. Diabetologia 2005 48 1637 1644 10.1007/s00125-005-1828-x 16021416
9. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. R Meerwaldt HL Lutgers TP Links R Graaff JW Baynes RO Gans, et al. Diabetes Care 2007 30 107 112 10.2337/dc06-1391 17192342
10. Advanced glycation end-products: a review. R Singh A Barden T Mori L Beilin, Diabetologia 2001 44 129 146 10.1007/s001250051591 11270668
11. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. AM Schmidt M Hasu D Popov JH Zhang J Chen SD Yan, et al. Proc Natl Acad Sci USA 1994 91 8807 8811 10.1073/pnas.91.19.8807 8090728
12. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. HL Lutgers R Graaff TP Links LJ Ubink-Veltmaat HJ Bilo RO Gans, et al. Diabetes Care 2006 29 2654 2659 10.2337/dc05-2173 17130200
13. Advanced glycation end products: sparking the development of diabetic vascular injury. A Goldin JA Beckman AM Schmidt MA Creager, Circulation 2006 114 597 605 10.1161/CIRCULATIONAHA.106.621854 16894049
14. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. HM Lander JM Tauras JS Ogiste O Hori RA Moss AM Schmidt, J Biol Chem 1997 272 17810 17814 10.1074/jbc.272.28.17810 9211935
15. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. MP Wautier O Chappey S Corda DM Stern AM Schmidt JL Wautier, Am J Physiol Endocrinol Metab 2001 280 685 E694 11287350
16. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. A Bierhaus S Chevion M Chevion M Hofmann P Quehenberger T Illmer, et al. Diabetes 1997 46 1481 1490 10.2337/diabetes.46.9.1481 9287050
17. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. PJ Thornalley, Cell Mol Biol (Noisy-le-grand) 1998 44 1013 1023 9846883
18. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. S Genuth W Sun P Cleary DR Sell W Dahms J Malone, et al. Diabetes 2005 54 3103 3111 10.2337/diabetes.54.11.3103 16249432
19. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. HL Lutgers EG Gerrits R Graaff TP Links WJ Sluiter RO Gans, et al. Diabetologia 2009 52 789 797 10.1007/s00125-009-1308-9 19274450
20. The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats. NL Alderson ME Chachich NN Youssef RJ Beattie M Nachtigal SR Thorpe, et al. Kidney Int 2003 63 2123 2133 10.1046/j.1523-1755.2003.00027.x 12753299
21. sRAGE is elevated in septic patients and associated with patients outcome. C Bopp S Hofer J Weitz A Bierhaus PP Nawroth E Martin, et al. J Surg Res 2008 147 79 83 10.1016/j.jss.2007.07.014 17981300
22. Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. C Bopp A Bierhaus S Hofer A Bouchon PP Nawroth E Martin, et al. Crit Care 2008 12 201 10.1186/cc6164 18226173
23. Advanced glycation endproducts: a biomarker for age as an outcome predictor after cardiac surgery? A Simm J Wagner T Gursinsky N Nass I Friedrich R Schinzel, et al. Exp Gerontol 2007 42 668 675 10.1016/j.exger.2007.03.006 17482402
24. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. CS Calfee LB Ware MD Eisner PE Parsons BT Thompson N Wickersham, et al. Thorax 2008 63 1083 1089 10.1136/thx.2008.095588 18566109
25. Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. CS Calfee MM Budev MA Matthay G Church S Brady T Uchida, et al. J Heart Lung Transplant 2007 26 675 680 10.1016/j.healun.2007.04.002 17613396